IE 11 is not supported. For an optimal experience visit our site on another browser.

Kim Kardashian flap spotlight’s FDA’s social media problem


After Kim Kardashian’s Instagram post endorsing a morning sickness drug drew a warning letter to the drug’s maker from the FDA, the spotlight has turned to legal requirements on all drug endorsements, including on social media, and how difficult that is to enforce. NBC’s Joe Fryer reports for TODAY.